Dr. Latour has served as our Chairman of the Board since December 2019, as a member of our board of directors since October 2011 and Chief Executive Officer from September 2011 to June 2020. From June to September 2011, Dr. Latour served as our Chief Operating Officer. Prior to that role, Dr. Latour was Chief Executive Officer and a member of the board of directors of Trinity Biosystems, Inc., a biopharmaceutical company. Dr. Latour previously held executive positions at various pharmaceutical and biotechnology companies including Genelabs, SmithKline Biologicals and Novartis. Dr. Latour received an M.D. from the University of Amsterdam and an M.B.A. from Stanford University.
